A preclinical study tested the effects of STL001 on PBMC and MM cell co-cultures (E:T 7:1) and compared the cytotoxicity to that of an anti-CD138 mAb and an anti-CD3 mAb combination and various controls (17). The gene discussed is SDC1; the disease is Miyoshi myopathy.